Difficulty: Medium
Average Score: 90%
Practice
A 9-mo-old infant is recently diagnosed with bilateral retinoblastoma; examination under anesthesia reveals bilateral multifocal involvement of the retina. An important next step in the management is
Correct answer
B
Rationale
In the case of a 9-month-old infant diagnosed with bilateral retinoblastoma with bilateral multifocal involvement of the retina, the important next step in management is retinal examination of 1st-degree relatives (Option B). This is crucial because retinoblastoma is a hereditary cancer, and early detection in family members is vital for timely intervention and better outcomes.
Radiotherapy of both eyes (Option A) is not the immediate next step as it may have significant side effects on the developing eyes and brain of an infant. Orbital ultrasonography (Option C) may not provide the necessary information for familial screening. Bilateral enucleation (Option D) is a drastic measure and is not the first-line management for bilateral retinoblastoma.
In an educational context, understanding the hereditary nature of retinoblastoma and the importance of family screening can help healthcare providers better manage cases, provide genetic counseling, and facilitate early detection in at-risk relatives. This case underscores the need for a comprehensive approach to pediatric oncology that includes genetic considerations and family involvement in decision-making.
Radiotherapy of both eyes (Option A) is not the immediate next step as it may have significant side effects on the developing eyes and brain of an infant. Orbital ultrasonography (Option C) may not provide the necessary information for familial screening. Bilateral enucleation (Option D) is a drastic measure and is not the first-line management for bilateral retinoblastoma.
In an educational context, understanding the hereditary nature of retinoblastoma and the importance of family screening can help healthcare providers better manage cases, provide genetic counseling, and facilitate early detection in at-risk relatives. This case underscores the need for a comprehensive approach to pediatric oncology that includes genetic considerations and family involvement in decision-making.